“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,” the members added.
Urge HHS, FDA, DHS, and CBP to delay implementation of new prescription-medicine import procedures unless they provide assurances that genuine personal-use prescription medicines can continue entering the United States.
Occurrences
“Americans should not lose access to affordable medicines simply because the government has better information about packages entering the country. We urge your agencies to use that information to focus enforcement on where the risks are greatest while preserving appropriate access to safe and affordable medicines for personal use,” the members concluded.
Evidence
unverified · Source version 79717 · locator unknown
“We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures”
unverified · Source version 79717 · locator unknown
"We urge HHS, FDA, DHS, and CBP to delay any implementation of new procedures with respect to prescription medicines unless you can provide clear assurances that your agencies will not prevent genuine prescription medicines clearly intended for personal use and not appearing to present an unreasonable risk from entering the United States,"
Assessments
No assessments yet.